Amgen (NQ: AMGN )
243.82 USD +3.50 (+1.46%) Official Closing Price Updated: 6:41 PM EDT, Sep 25, 2020 Add to My Watchlist
Press releases about Amgen
Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
September 20, 2020
Confirmed and Durable Anticancer Activity in Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients From Phase 1 Trial
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies
September 17, 2020
Agreement will significantly increase global supply capacity for Lilly's potential COVID-19 treatments
Amgen To Webcast Investor Calls At ESMO 2020
September 16, 2020
Amgen (NASDAQ:AMGN) will host two webcast calls for the investment community in conjunction with the European Society for Medical Oncology (ESMO) 2020 Virtual Congress. On Sunday, Sept. 20, 2020, at...
Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket
September 15, 2020
Two Biotherapeutic Companies Receive Lab Space and Other Benefits to Further Advance Innovative Science at Bay Area Life Sciences Incubator
Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference
September 14, 2020
Amgen (NASDAQ:AMGN) will present at the Bank of America Virtual Global Healthcare Conference at 12:35 p.m. ET on Thursday, Sept. 17, 2020. Peter H. Griffith, executive vice president and chief...
Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference at 11:45 a.m. ET on Wednesday, Sept. 16, 2020. Robert A. Bradway, chairman and chief executive...
Medical Device Innovation Helps Propel Healthcare Systems to New Standards
September 08, 2020
Amgen To Present At The 15th Annual Citi BioPharma Conference
September 04, 2020
Amgen (NASDAQ:AMGN) will present at Citi's 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon, executive vice president of Global Commercial Operations...
Thinking about trading options or stock in Amgen, American Express, Nvidia, Paypal, or Apple?
September 04, 2020
eToro Pick Healthcare Market Movers: $ABBV $ABT $AMGN
September 03, 2020
Tags The Market Signal
From The Market Signal
Humoral immune response to SARS-CoV2 in Iceland
September 01, 2020
Amgen Announces Positive Data From Phase 3B Study Of Repatha® (Evolocumab) In Pediatric Patients With Heterozygous Familial Hypercholesterolemia At ESC Congress 2020
August 29, 2020
First Phase 3 Trial Evaluating a PCSK9 Inhibitor When Added to Lipid-Lowering Therapy in Pediatric HeFH Population
New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha® (evolocumab) Efficacy In High-Risk Patient Populations
August 25, 2020
Repatha (Evolocumab) Late-Breaking Data Showcase First Phase 3 Study of a PCSK9 Inhibitor in Pediatric Heterozygous Familial Hypercholesterolemia
Thinking about trading options or stock in Exxon Mobil Corporation, United Airlines, salesforce.com, Amgen, Inc., or Tortoise Acquisition Corp Class A?
August 25, 2020
Salesforce.com, Amgen and Honeywell International Set to Join Dow Jones Industrial Average
August 24, 2020
S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) effective prior to the opening of trading on Monday, August 31:
Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myel
August 24, 2020
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that a major Captisol customer Amgen (NASDAQ: AMGN) has received U.S. Food and Drug Administration (FDA) approval for the expansion of the...
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens
August 20, 2020
Approval Based on the CANDOR and EQUULEUS Studies in Patients With Relapsed/Refractory Multiple Myeloma
Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes
August 13, 2020
Amgen Inc. (NASDAQ:AMGN) announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers")...
Amgen Inc. (NASDAQ:AMGN) announced today the early tender results of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange...
Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial
August 03, 2020
- I-SPY COVID will evaluate the impact of cenicriviroc, Otezla®, and Firazyr® on inflammatory response in COVID-19 patients
Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders
July 30, 2020
Amgen Inc. (NASDAQ: AMGN) announced today the commencement of nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") certain specified series of...
Amgen Reports Second Quarter 2020 Financial Results
July 28, 2020
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets. The announcement will be followed...
Amgen Announces 2020 Third Quarter Dividend
July 23, 2020
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will be paid on September 8, 2020, to all stockholders of...
Amgen Appoints Amy E. Miles To Board Of Directors
July 23, 2020
Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020. Ms. Miles will serve as a member of the Board's Audit Committee and Governance and Nominating...
Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19
July 21, 2020
Foundation Expands Five-Year Relationship to Include Support for School Districts Facing Deep Budget Cuts